LENZ Therapeutics, Inc. - Common Stock, $0.00001 par value per share (LENZ)

Q: What does CUSIP 52635N103 represent in this 13F holders report?

CUSIP 52635N103 is the security identifier for LENZ - LENZ Therapeutics, Inc. - Common Stock, $0.00001 par value per share used to aggregate holder disclosures.

Q: How many institutions held LENZ - LENZ Therapeutics, Inc. - Common Stock, $0.00001 par value per share in Q2 2025?

113 institutional investors reported LENZ - LENZ Therapeutics, Inc. - Common Stock, $0.00001 par value per share for Q2 2025. Use the holders table for investor-level position and value details.

CUSIP: 52635N103

Q2 2025 13F Holders as of 30 Jun 2025

Security type / class: Equity / Common Stock, $0.00001 par value per share
Total 13F shares: 24,727,156
Total 13F value: $725,109,733
Share change: +3,653,975
Put/Call ratio: 2.7%
SEC-reported price per share: $29.31
Number of holders: 113
Value change: +$107,969,187
Number of buys: 76
Number of sells: 31
Shares outstanding: 31,503,388

Security key

52635N103

Report period

Q2 2025

Institutions

113

Top holders

LENZ full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2026 LENZ Therapeutics, Inc. SEC filings LENZ Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 52635N103

Newer quarter: Q3 2026

Recent filing periods:

Q3 2026

Ownership snapshot

Top reported holders of LENZ - LENZ Therapeutics, Inc. - Common Stock, $0.00001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

EcoR1 Capital, LLC

Disclosed value leader

RA CAPITAL MANAGEMENT, L.P.

Comparable rows

0/15

Latest evidence

31 Mar 2025

3/4/5 13F Highest disclosed value: $107,437,539 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

RA CAPITAL MANAGEMENT, L.P. has the largest disclosed position value at $107.44M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.

Disclosed position value Top 5

EcoR1 Capital, LLC $34.84M

Samsara BioCapital, L.P. $34.67M

Versant Venture Capital VII, L.P. $6.52M

RA CAPITAL MANAGEMENT, L.P. $107.44M

Alpha Wave Global, LP $92.87M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
EcoR1 Capital, LLC	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$34,836,860 8,538,446 shares	—	06 Jan 2023
Samsara BioCapital, L.P.	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$34,668,033 8,497,067 shares	—	11 Apr 2022
Versant Venture Capital VII, L.P.	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$6,523,059 1,598,789 shares	—	21 Mar 2024
Alpha Wave Ventures GP, Ltd	3/4/5 10%+ Owner 3/4/5	— denominator unverified	— 3,612,211 shares	—	21 Mar 2024
RA CAPITAL MANAGEMENT, L.P.	13F Company 13F	— denominator unverified	$107,437,539 4,178,823 shares	—	31 Mar 2025
Alpha Wave Global, LP	13F Company 13F	— denominator unverified	$92,869,945 3,612,211 shares	—	31 Mar 2025

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

113

24,727,156

Rows available

113

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders

105

Q2 2025 holders

113

Holder diff

Investor	Q1 2025 Shares	Q2 2025 Shares	Share Diff	Share Chg %	Q1 2025 value	Q2 2025 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend